中间葡萄膜炎并发血管增生性肿瘤
七家葡萄膜炎/眼肿瘤中心回顾性收集34例(36眼)中间葡萄膜炎并发血管增生性肿瘤(VPT)患者资料。所有眼在VPT诊断时中间葡萄膜炎均处于活动期,平均VPT厚度3.06±0.86 mm;22眼接受VPT局部治疗,14眼未接受。随访35.8个月,局部治疗的22个VPT厚度降至1.25 mm,未治疗的14个VPT保持稳定(最终平均厚度2.65 mm);随访眼底荧光血管造影显示94.4%的眼血管渗漏消退。作者结论认为活动性中间葡萄膜炎伴VPT提示需要积极的葡萄膜炎治疗。
要点
- 所有36眼在VPT诊断时中间葡萄膜炎均处于活动期,平均VPT厚度3.06±0.86 mm。
- 随访35.8个月,局部治疗的22个VPT厚度降至1.25 mm,未治疗的14个VPT保持稳定(最终平均厚度2.65 mm)。
- 随访眼底荧光血管造影显示94.4%的眼血管渗漏消退。
核心结论
- 作者认为,活动性中间葡萄膜炎伴VPT提示需要积极的葡萄膜炎治疗。
研究设计与样本
- 在七家葡萄膜炎/眼肿瘤中心收集患者的人口学、基线和随访眼科检查及影像学资料。
- 记录治疗干预、最终视力和随访时长。
- 共纳入34例患者(12男,22女;平均年龄35.3±14.2岁)的36眼。
主要发现
- 就诊时视力范围为20/40至数指。
- VPT诊断时所有眼中间葡萄膜炎均处于活动期,平均VPT厚度3.06±0.86 mm。
- 22眼(61.1%)接受VPT局部治疗,14眼(38.9%)未接受VPT局部治疗。
- VPT发现后开始针对炎症的全身或局部治疗,随访眼底荧光血管造影显示94.4%的眼血管渗漏消退。
- 随访35.8个月,局部治疗的22个VPT厚度降至1.25 mm,未治疗的14个VPT保持稳定(最终平均肿瘤厚度2.65 mm)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe patients with intermediate uveitis complicated by vasoproliferative tumors (VPTs). METHODS: Data were collected at seven Uveitis/Ocular Oncology centers on demographic, ophthalmic findings at baseline and at follow-up, and on imaging. The therapeutic intervention, final visual acuity, and duration of follow-up were recorded. RESULTS: A total of 36 eyes from 34 patients (12 men, 22 women; mean age 35.3 ± 14.2 years) were included in this study. Visual acuity at presentation ranged from 20/40 to counting fingers. At the time of VPT diagnosis, intermediate uveitis was active in all eyes. The mean VPT thickness was 3.06 ± 0.86 mm. Local treatment to the VPT was provide in 22 eyes (61.1%) and no local treatment to the VPT in 14 eyes (38.9%). After the VPT was detected, systemic or local treatment for the inflammation was initiated and on follow-up FAs 94.4% of the eyes showed resolution of the vascular leakage. During follow-up of 35.8 months, the 22 VPTs treated locally had a reduction in the tumor thickness to 1.25 mm, whereas the 14 VPTs untreated remained stable (final mean tumor thickness 2.65 mm). CONCLUSION: The presence of active intermediate uveitis accompanied by VPTs suggests the need for an aggressive uveitis treatment.
引用
- Pichi F, Neri P, Agarwal A, et al. VASOPROLIFERATIVE TUMORS IN INTERMEDIATE UVEITIS. Retina. 2020. PMID: 31584561. doi:10.1097/IAE.0000000000002656
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。